All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

European regulation on orphan medicinal products: 10 years of experience and future perspectives

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F11%3A10293954" target="_blank" >RIV/00064203:_____/11:10293954 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11130/11:10293954

  • Result on the web

    <a href="http://dx.doi.org/10.1038/nrd3445" target="_blank" >http://dx.doi.org/10.1038/nrd3445</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1038/nrd3445" target="_blank" >10.1038/nrd3445</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    European regulation on orphan medicinal products: 10 years of experience and future perspectives

  • Original language description

    In 2000, regulation on orphan medicinal products was adopted in the European Union with the aim of benefiting patients who suffer from serious, rare conditions for which there is currently no satisfactory treatment. Since then, more than 850 orphan drugdesignations have been granted by the European Commission based on a positive opinion from the Committee for Orphan Medicinal Products (COMP), and more than 60 orphan drugs have received marketing authorization in Europe. Here, stimulated by the tenth anniversary of the COMP, we reflect on the outcomes and experience gained in the past decade, and contemplate issues for the future, such as catalysing drug development for the large number of rare diseases that still lack effective treatments.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2011

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Nature Reviews Drug Discovery

  • ISSN

    1474-1776

  • e-ISSN

  • Volume of the periodical

    10

  • Issue of the periodical within the volume

    5

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    9

  • Pages from-to

    341-349

  • UT code for WoS article

    000290017300016

  • EID of the result in the Scopus database